California Stem Cell Merger: Capricor and Niles Therapeutics
Capricor, Inc., a Beverly Hills company benefiting from $27 million from the California stem cell agency, this week announced that it is merging with Niles Therapeutic, Inc., of San Mateo.
Linda Marban
Capricor photo
The Capricor story and its treatment for heart disease have been highlighted (see here and here) by the $3 billion state research agency, whi…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.